The clinical value of diffusion-weighted magnetic resonance imaging for localization of prostate cancer-comparison with the step sections of radical prostatectomy

Japanese Journal of Urology

Volumn 101, Issue 4, 2010, Pages 603-608

  Hatano, Koji ^a   Tsuda, Kyo ^a   Kawamura, Norihiko ^a   Kakuta, Yoichi ^a   Takada, Tsuyoshi ^a   Adachi, Shiro ^a   Hara, Tsuneo ^a   Yamaguchi, Seiji ^a  

^a Ikeda Municipal Hospital   (Japan)

Author keywords

Diffusion weighted imaging; Magnetic resonance imaging; Prostate cancer

Indexed keywords

EID: 77953168473     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol.101.603     Document Type: Article

References (23)

1. Kubota Y., Ito K., Imai K. and Yamanaka H.: Effective of mass screening for the prognosis of prostate cancer patients in Japanese communities. Prostate, 50, 262-269, 2002. (Pubitemid 34184666)
2. Catalona W.J., Richie J.P., Ahmann F.R., Hudson M. A., Scardino P.T., Flanigan R.C., deKernion J.B., Ratliff T.L., Kavoussi L.R. and Dalkin B.L.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6, 630 men. J Urol., 151, 1283-1290, 1994.
3. Ito K., Ichinose Y., Kubota Y., Imai K. and Yamanaka H.: Clinicopathological features of prostate cancer detected by transrectal ultrasonography-guided systematic six-sextant biopsy. Int J Urol., 4, 474-479, 1997. (Pubitemid 27507497)
4. Jager G.J., Severens J.L., Thornbury J.R., de La Rosette J.J., Ruijs S.H. and Barentsz J.O.: Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology., 215, 445-451, 2000.
5. Zelhof B., Pickles M., Liney G., Gibbs P., Rodrigues G., Kraus S. and Turnbull L.: Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU. Int., 103, 883-888, 2009.
6. Haider M.A., van der Kwast T.H., Tanguay J., Evans A.J., Hashimi A.T., Lockwood G. and Trachtenberg J.: Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR. Am. J. Roentgenol., 189, 323-328, 2007.
7. Shimofusa R., Fujimoto H., Akamata H., Motoori K., Yamamoto S., Ueda T. and Ito H.: Diffusion weighted imaging of prostate cancer. J. Comput Assist. Tomogr., 29, 149-153, 2005.
8. Tanimoto A., Nakashima J., Kohno H., Shinmoto H. and Kuribayashi S.: Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2weighted imaging. J. Magn. Reson. Imaging., 25, 146-152, 2007.
9. Miao H., Fukatsu H. and Ishigaki T.: Prostate cancer detection with 3-T MRI: comparison of diffusionweighted and T2-weighted imaging. Eur. J. Radiol., 61, 297-302, 2007.
10. Kajihara H., Hayashida Y., Murakami R., Katahira K., Nishimura R., Hamada Y., Kitani K., Kitaoka M., Suzuki Y., Kitajima M., Hirai T., Morishita S., Awai K. and Yamashita Y.: Usefulness of diffusionweighted imaging in the localization of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys., 74, 399-403, 2009.
11. Kim C.K., Park B.K., Lee H.M. and Kwon G.Y.: Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Invest Radiol., 42, 842-847, 2007.
12. Sobin LH. and Wittekind Ch.: TNM Classification of Malignant Tumors. 5th ed, Wiley-Liss, 1997.
13. Hricak H., Dooms G.C., McNeal J.E., Mark A.S., Marotti M., Avallone A., Pelzer M., Proctor E.C. and Tanagho E.A.: MR imaging of the prostate gland: normal anatomy. AJR. Am. J. Roentgenol., 148, 51-58, 1987.
14. Jager G.J., Ruijter E.T., van de Kaa C.A., de la Rosette J.J., Oosterhof G.O., Thornbury J.R., Ruijs S.H. and Barentsz J.O.: Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology, 203, 645-652, 1997.
15. Ogura K., Maekawa S., Okubo K., Aoki Y., Okada T., Oda K., Watanabe Y., Tsukayama C. and Arai Y.: Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology., 57, 721-726, 2001.
16. Minematsu K., Li L., Fisher M., Sotak C.H., Davis M.A. and Fiandaca M.S.: Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia Neurology., 42, 235-240, 1992.
17. Chenevert T.L., McKeever P.E. and Ross B.D.: Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin. Cancer. Res., 3, 1457-1466, 1997.
18. Guo Y., Gai Y.Q., Cai Z.L., Gao Y.G., An N.Y., Ma L., Mahankali S. and Gao J. H.: Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J. Magn. Reson. Imaging, 16, 172-178, 2002.